Literature DB >> 28743936

HCV elimination - lessons learned from a small Eurasian country, Georgia.

Muazzam Nasrullah1, David Sergeenko2, Amiran Gamkrelidze3, Francisco Averhoff1.   

Abstract

Mesh：

Year:  2017        PMID： 28743936     DOI： 10.1038/nrgastro.2017.100

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  6 in total

1.  Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.

Authors:  Narcyz Ghinea; Wendy Lipworth; Richard Day; Andrew Hill; Gregory J Dore; Mark Danta
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

2.  Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.

Authors:  Ilias Gountas; Vana Sypsa; George Papatheodoridis; George Souliotis; Homie Razavi; Angelos Hatzakis
Journal:  J Gastroenterol Hepatol       Date:  2017-02       Impact factor: 4.029

Review 3.  From non-A, non-B hepatitis to hepatitis C virus cure.

Authors:  Jean-Michel Pawlotsky; Jordan J Feld; Stefan Zeuzem; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

4.  National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.

Authors:  Lia Gvinjilia; Muazzam Nasrullah; David Sergeenko; Tengiz Tsertsvadze; George Kamkamidze; Maia Butsashvili; Amiran Gamkrelidze; Paata Imnadze; Valeri Kvaratskhelia; Nikoloz Chkhartishvili; Lali Sharvadze; Jan Drobeniuc; Liesl Hagan; John W Ward; Juliette Morgan; Francisco Averhoff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-10-21       Impact factor: 17.586

5.  Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.

Authors:  Nick Scott; Emma S McBryde; Alexander Thompson; Joseph S Doyle; Margaret E Hellard
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

6.  Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium.

Authors:  S Bourgeois; S Blach; C Blach; W Laleman; C Matheï; J P Mulkay; H Ravazi; G Robaeys; P Stärkel; P Van Damme; H Van Vlierberghe; D Vandijck; C Vandijck
Journal:  Acta Gastroenterol Belg       Date:  2016 Apr-Jun       Impact factor: 1.316
  6 in total
  9 in total

Review 1.  Hepatitis C elimination: a Public Health Perspective.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

2.  Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.

Authors:  Francisco Averhoff; Shaun Shadaker; Amiran Gamkrelidze; Tatia Kuchuloria; Lia Gvinjilia; Vladimer Getia; David Sergeenko; Maia Butsashvili; Tengiz Tsertsvadze; Lali Sharvadze; Jaba Zarkua; Beth Skaggs; Muazzam Nasrullah
Journal:  J Hepatol       Date:  2019-12-04       Impact factor: 25.083

Review 3.  Breakthroughs in hepatitis C research: from discovery to cure.

Authors:  Michael P Manns; Benjamin Maasoumy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-20       Impact factor: 73.082

Review 4.  The Elimination of Hepatitis C as a Public Health Threat.

Authors:  Margaret Hellard; Sophia E Schroeder; Alisa Pedrana; Joseph Doyle; Campbell Aitken
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

5.  The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.

Authors:  M Behzadifar; S Azari; H A Gorji; M Martini; N L Bragazzi
Journal:  J Prev Med Hyg       Date:  2020-04-02

6.  Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia.

Authors:  Masoud Behzadifar; Hasan Abolghasem Gorji; Aziz Rezapour; Nicola Luigi Bragazzi
Journal:  J Virus Erad       Date:  2019-04-01

Review 7.  Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.

Authors:  Danijel Galun; Dragana Mijac; Aleksandar Filipovic; Aleksandar Bogdanovic; Marko Zivanovic; Dragan Masulovic
Journal:  J Pers Med       Date:  2022-01-24

Review 8.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

9.  Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

Authors:  Rachel Sacks-Davis; Joseph S Doyle; Andri Rauch; Charles Beguelin; Alisa E Pedrana; Gail V Matthews; Maria Prins; Marc van der Valk; Marina B Klein; Sahar Saeed; Karine Lacombe; Nikoloz Chkhartishvili; Frederick L Altice; Margaret E Hellard
Journal:  J Int AIDS Soc       Date:  2018-04       Impact factor: 5.396
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.